Pibrentasvir and its Impurities

Pibrentasvir used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6. It is an NS5A inhibitor antiviral agent.Reference standards of Pibrentasvir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 7 results for Pibrentasvir Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 69 28000

Pibrentasvir

Pibrentasvir


  • Catalogue No.:PA 69 28000

  • CAS :

    1353900-92-1

  • Molecular Formula : C57H65F5N10O8

  • Molecular Weight : 1113.20

Drug Reference Standards & Impurity Synthesis in India
PA 69 0281000

5,5'-[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl-1H-benzimidazole]

5,5'-[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl-1H-benzimidazole]


  • Catalogue No.:PA 69 0281000

  • CAS :

    1332357-14-8

  • Molecular Formula : C43H43F5N8

  • Molecular Weight : 766.87

Drug Reference Standards & Impurity Synthesis in India
PA 69 0281001

(2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester

(2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-1-pyrrolidinecarboxylic acid 1,1'-bis(1,1-dimethylethyl) ester


  • Catalogue No.:PA 69 0281001

  • CAS :

    1890114-11-0

  • Molecular Formula : C53H59F5N8O4

  • Molecular Weight : 967.1

Drug Reference Standards & Impurity Synthesis in India
PA 69 0281002

3,5-Difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]aniline

3,5-Difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]aniline


  • Catalogue No.:PA 69 0281002

  • CAS :

    1332356-31-6

  • Molecular Formula : C17H17F3N2

  • Molecular Weight : 306.33

Drug Reference Standards & Impurity Synthesis in India
PA 69 0281003

(1S,4S)-1,4-Bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-diol

(1S,4S)-1,4-Bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-diol


  • Catalogue No.:PA 69 0281003

  • CAS :

    1292836-20-4

  • Molecular Formula : C16H12Cl2F2N2O6

  • Molecular Weight : 437.18

Drug Reference Standards & Impurity Synthesis in India
PA STI 089201

Pibrentasvir-D6

Pibrentasvir-D6


  • Catalogue No.:PA STI 089201

  • CAS :

    NA

  • Molecular Formula : C57H59D6F5N10O8

  • Molecular Weight : 1119.24

Drug Reference Standards & Impurity Synthesis in India
PA 69 0281004

Methyl ((2S,3R)-1-((S)-2-(6-((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)-5-(5-fluoro-2-((R)-1-(N-(methoxycarbonyl)-O-methyl-L-threonyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)pyrrolidin-2-yl)-5-fluoro-1H-benzo[d]imidazol-2-yl)pyrrolidin-1-yl)-3-methoxy-1-oxobutan-2-yl)carbamate

Methyl ((2S,3R)-1-((S)-2-(6-((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)-5-(5-fluoro-2-((R)-1-(N-(methoxycarbonyl)-O-methyl-L-threonyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)pyrrolidin-2-yl)-5-fluoro-1H-benzo[d]imidazol-2-yl)pyrrolidin-1-yl)-3-methoxy-1-oxobutan-2-yl)carbamate


  • Catalogue No.:PA 69 0281004

  • CAS :

    2412432-58-5

  • Molecular Formula : C57H65F5N10O8

  • Molecular Weight : 1113.2

pharmaffiliates